{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:15:54Z","timestamp":1791090954544,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.eururo.2009.12.022","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T10:27:23Z","timestamp":1261132043000},"page":"884-890","source":"Crossref","is-referenced-by-count":87,"title":["Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder"],"prefix":"10.1016","volume":"57","author":[{"given":"Ana","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Dinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Gorgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia D.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Avelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2009.12.022_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOU.0b013e32832ae176","article-title":"Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?","volume":"19","author":"Silva","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpurol.2009.01.005","article-title":"Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"5","author":"Gam\u00e9","year":"2009","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/1.4.656","article-title":"The action of botulinal toxin","volume":"1","author":"Simpson","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.eururo.2009.12.022_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","article-title":"Drug insight: biological effects of botulinum toxin A in the lower urinary tract","volume":"5","author":"Chancellor","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.eururo.2009.12.022_bib9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jor.20131","article-title":"How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats","volume":"24","author":"Shen","year":"2006","journal-title":"J Orthop Res"},{"key":"10.1016\/j.eururo.2009.12.022_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0041-0101(01)00082-4","article-title":"Correlation of cleavage of SNAP-25 with muscle function in a rat model of botulinum neurotoxin type A induced paralysis","volume":"39","author":"Jurasinski","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.eururo.2009.12.022_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1083\/jcb.100.4.1284","article-title":"Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells","volume":"100","author":"Bucley","year":"1985","journal-title":"J Cell Biol"},{"key":"10.1016\/j.eururo.2009.12.022_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0306-4522(01)00496-1","article-title":"Vanilloid receptor 1 expression in the rat urinary tract","volume":"109","author":"Avelino","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.eururo.2009.12.022_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1520-6777(2000)19:2<185::AID-NAU9>3.0.CO;2-2","article-title":"The distribution of vesicular acetylcholine transporter in the human male genitourinary organs and its co-localization with neuropeptide Y and nitric oxide synthase","volume":"19","author":"Dixon","year":"2000","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2009.12.022_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000052314","article-title":"The distribution of noradrenergic nerves in the human lower urinary tract. A review","volume":"36","author":"Gosling","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.coph.2007.09.004","article-title":"Role of visceral afferent neurons in mucosal inflammation and defense","volume":"7","author":"Holzer","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.eururo.2009.12.022_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1464-410X.2003.03802.x","article-title":"The role of the human bladder lamina propria myofibroblast","volume":"91","author":"Wiseman","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.12.022_bib17","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.eururo.2008.11.009","article-title":"Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment","volume":"55","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib18","first-page":"37","article-title":"Distribution and co-localization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder","volume":"77","author":"Smet","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.eururo.2009.12.022_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1113\/jphysiol.1962.sp006843","article-title":"Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin","volume":"160","author":"Hughes","year":"1962","journal-title":"J Physiol"},{"key":"10.1016\/j.eururo.2009.12.022_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.870120115","article-title":"The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans","volume":"12","author":"Eleopra","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.eururo.2009.12.022_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.eururo.2009.12.022_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib24","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1523\/JNEUROSCI.21-15-05670.2001","article-title":"P2X3 knock-out mice reveal a major sensory role for urothelially released ATP","volume":"21","author":"Vlaskovska","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2009.12.022_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib27","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity","volume":"279","author":"Morenilla-Palao","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2009.12.022_bib28","first-page":"9","article-title":"Modification of bladder structure in response to outflow obstruction and ageing","volume":"32","author":"Gosling","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.12.022_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","article-title":"Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment","volume":"93","author":"Brady","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2009.12.022_bib30","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin type A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380901269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380901269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:50:44Z","timestamp":1558702244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228380901269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S030228380901269X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2009.12.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1649968.1152067","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}